Free subscription

Subscribe to our newsletter and keep yourself updated

Balkan Events

The North Macedonian pharmaceutical company Replec is planning an investment of 13 million euro by 2027.

05 february 2025

North Macedonian drugmaker Replec plans to invest EUR 13 million in strategic projects by the end of 2027, BalkanEngineer.com has learned from SeeNews.com. The company will focus on expanding its product portfolio and strengthening its competitiveness in the market.

 

 

The North Macedonia-based drugmaker Replec announced that it will invest EUR 13 million over the period 2025-2027 for strategic development and expansion of its operations. The main objectives of the investment include increasing market share and significantly strengthening the company's competitive position in the pharmaceutical market.

 

Replek plans to focus its efforts on digitalization and automation of the production process, as well as on improving working conditions for its employees. The company has the ambitious goal of achieving 25% annual sales growth by expanding its product portfolio and introducing innovations.

 

In December 2024, Replek also announced plans to open a subsidiary in Bosnia and Herzegovina and invest in new production facilities in 2025. Sales for 2025 are forecast to reach €39 million, a 25% increase on the previous year.

 

The company was also included in the prestigious index of the Macedonian Stock Exchange - MBI-10, which highlights its growth and stability in the financial markets.

 

 

Photo source: ©Engineer.BG via Canva

Balkan News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

see all »

Balkan Events

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

see all »